BAX - Baxter International Inc. -  [ ]

Ticker Details
Baxter International Inc.
Baxter International Inc operates in the healthcare industry. It provides renal and hospital products such as infusion systems and systems, parenteral nutrition therapies, and biosurgery products.
IPO Date: January 2, 1990
Sector: Healthcare
Industry: Health Care Equipment and Supplies
Market Cap: $12.3B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.54 | 1.04%
Avg Daily Range (30 D): $0.43 | 1.64%
Avg Daily Range (90 D): $0.43 | 1.95%
Institutional Daily Volume
Avg Daily Volume: 3.41M
Avg Daily Volume (30 D): 4.76M
Avg Daily Volume (90 D): 5.09M
Trade Size
Avg Trade Size (Sh.): 142
Avg Trade Size (Sh.) (30 D): 83
Avg Trade Size (Sh.) (90 D): 91
Institutional Trades
Total Institutional Trades: 64,326
Avg Institutional Trade: $3.84M
Avg Institutional Trade (30 D): $5.12M
Avg Institutional Trade (90 D): $5.32M
Avg Institutional Trade Volume: .08M
Avg Institutional Trades (Per Day): 11
Market Closing Trades
Avg Closing Trade: $20.49M
Avg Closing Trade (30 D): $28.06M
Avg Closing Trade (90 D): $26.69M
Avg Closing Volume: 416.18K
 
News
Sep 10, 2026 @ 12:30 AM
Intravenous Immunoglobulin Market Size Worth USD 3...
Source: Sns Insider
Sep 7, 2026 @ 10:57 AM
Drug Reconstitution Systems Market Trends, Shares ...
Source: Researchandmarkets.Com
Aug 1, 2026 @ 12:03 AM
Why Baxter International Stock Skyrocketed by 19% ...
Source: Eric Volkman
Jul 1, 2026 @ 4:30 AM
Global Human Fibrinogen Concentrate Market Size/Sh...
Source: Healthcare Foresights
May 7, 2026 @ 8:14 AM
Becton Dickinson at 13x Earnings: MedTech’s...
Source: Gurufocus
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.07 $.24 $-.02
Diluted EPS $-2.08 $.24 $-.03
Revenue $11.47B $2.96B $2.7B
Gross Profit $3.45B $1.03B $891M
Net Income / Loss $-1063M $126M $-15M
Operating Income / Loss $-274M $217M $66M
Cost of Revenue $8.02B $1.93B $1.81B
Net Cash Flow $384M
PE Ratio    
Splits
May 31, 2001 2:1